Dr. Dawn C Allicock, M.D.,MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Medicare Enrolled Practice Location: 200 San Sebastian Vw, St Augustine, FL 32084 Phone: 904-209-3250 Fax: 904-823-2580 |
News Archive
The information gap and general lack of understanding of obesity's unique and disproportionate impact on women contributes to the challenges of the 65 million American women who are considered overweight or obese, said the Strategies to Overcome and Prevent (STOP) Obesity Alliance Task Force on Women at a meeting on Capitol Hill today.
TONIX Pharmaceuticals (formerly known as Krele Pharmaceuticals), a specialty central nervous system (CNS) pharmaceutical company, announced results of a new analysis of a Phase 2a study, which previously demonstrated reduced pain, fatigue and tenderness in patients with Fibromyalgia Syndrome (FMS) following bedtime administration of very low dosage (VLD) cyclobenzaprine (CBP).
QLT Inc. today announced results from a Phase II proof-of-concept clinical trial for the olopatadine punctal plug delivery system (O‑PPDS).
Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.
A multi-institutional, international team of scientists has discovered the genetic cause and biological mechanisms linked to a new human immunodeficiency. The study, which is published in Nature Immunology, also identifies a potential treatment.
› Verified 3 days ago